Ignite Creation Date:
2024-05-06 @ 7:30 PM
Last Modification Date:
2024-10-26 @ 3:08 PM
Study NCT ID:
NCT06035016
Status:
RECRUITING
Last Update Posted:
2023-09-13
First Post:
2023-09-06
Brief Title:
Pyrotinib Plus Capecitabine for Adjuvant Treatment of HER2 Positive Early-stage Breast Cancer
Sponsor:
Peking Union Medical College Hospital
Organization:
Peking Union Medical College Hospital
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Early-stage Breast Cancer |
| HER2-positive Breast Cancer |
Keywords: